Evidence map›Paper›PMID 17549259›Full record

ArticleThe Journal of clinical investigation2007

Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo.

Raogo Ouedraogo, Yulan Gong, Brett Berzins, Xiandong Wu, Kalyankar Mahadev, Kelly Hough, Lawrence Chan, Barry J Goldstein, Rosario Scalia

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 121 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
121citing papers in PubMed, 1 pooled it
12.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

121 citing papers in PubMed, 1 synthesis or guideline pooled it, 264 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Review
  7. Hepatoprotective and Antiatherosclerotic Effects of Oleoylethanolamide-Based Dietary Supplement in Dietary-Induced Obesity in Mice.Pathophysiology : the official journal of the International Society for Pathophysiology · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

61 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Raogo OuedraogoDivision of Endocrinology, Diabetes, and Metabolic Diseases, Department of Medicine, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania 19107-6799, USA.
Yulan Gong
Brett Berzins
Xiandong Wu
Kalyankar Mahadev
Kelly Hough
Lawrence Chan
Barry J Goldstein
Rosario Scalia
Diabetes Australia · AUThomas Jefferson University · US

Funding

MODELS FOR ATHEROSCLEROSIS RESEARCHR01HL051586 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI CHAN, LAWRENCE · 1994 to 2014
$5.5M
Role of Calpain in Diabetic Endothelial DysfunctionR01DK064344 · NIDDK · THOMAS JEFFERSON UNIVERSITY · PI SCALIA, ROSARIO G · 2003 to 2011
$2.7M
NOVEL THERAPY FOR DIABETESR01DK068037 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI CHAN, LAWRENCE · 2004 to 2008
$2.1M
Adiponectin Improves Vascular Function In High GlucoseR01DK071360 · NIDDK · THOMAS JEFFERSON UNIVERSITY · PI WILLIAMS, KEVIN JON · 2004 to 2007
$1.4M
Adiponectin: Vascular Responses and Signaling MechanismsR01DK063018 · NIDDK · THOMAS JEFFERSON UNIVERSITY · PI WILLIAMS, KEVIN JON · 2004 to 2007
$1.4M
NHLBI NIH HHS HL51586NHLBI NIH HHS R01 HL051586NIDDK NIH HHS DK064344NIDDK NIH HHS DK63018NIDDK NIH HHS DK68037NIDDK NIH HHS DK71360NIDDK NIH HHS R01 DK063018NIDDK NIH HHS R01 DK064344NIDDK NIH HHS R01 DK068037NIDDK NIH HHS R01 DK071360
6 · The paper itself

Abstract

This study reports on what we believe are novel mechanism(s) of the vascular protective action of adiponectin. We used intravital microscopy to measure leukocyte-endothelium interactions in adiponectin-deficient (Ad(-/-)) mice and found that adiponectin deficiency was associated with a 2-fold increase in leukocyte rolling and a 5-fold increase in leukocyte adhesion in the microcirculation. Measurement of endothelial NO (eNO) revealed that adiponectin deficiency drastically reduced levels of eNO in the vascular wall. Immunohistochemistry demonstrated increased expression of E-selectin and VCAM-1 in the vascular endothelium of Ad(-/-) mice. Systemic administration of the recombinant globular adiponectin domain (gAd) to Ad(-/-) mice significantly attenuated leukocyte-endothelium interactions and adhesion molecule expression in addition to restoring physiologic levels of eNO. Importantly, prior administration of gAd also protected WT mice against TNF-alpha-induced leukocyte-endothelium interactions, indicating a pharmacologic action of gAd. Mechanistically, blockade of eNOS with N(omega)-nitro-L-arginine methyl ester ( L-NAME) abolished the inhibitory effect of gAd on leukocyte adhesion, demonstrating the obligatory role of eNOS signaling in the antiinflammatory action of gAd. We believe this is the first demonstration that gAd protects the vasculature in vivo via increased NO bioavailability with suppression of leukocyte-endothelium interactions. Overall, we provide evidence that loss of adiponectin induces a primary state of endothelial dysfunction with increased leukocyte-endothelium adhesiveness.

Indexed as

AdiponectinAnimalsCell AdhesionEndothelial CellsE-SelectinIn Vitro TechniquesLeukocyte RollingLeukocytesMaleMiceMice, Inbred C57BLMice, KnockoutNitric OxideProtein Structure, TertiaryRecombinant ProteinsUp-RegulationAdiponectinAdipoq protein, mouseE-SelectinNitric OxideRecombinant ProteinsVascular Cell Adhesion Molecule-1

Identifiers

PMID17549259
PMCPMC1878515
OpenAlexW2046618596

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.